D.L.S.I. Logo

D.L.S.I.

HR and recruitment services for temp, fixed-term, and permanent roles across industries.

ALDLS | PA

Overview

Corporate Details

ISIN(s):
FR0010404368
LEI:
969500EJ1VXQBOHQR803
Country:
France
Address:
Avenue Eric Bousch, 57600 Forbach
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Groupe DLSI is a human resources and recruitment services company specializing in temporary staffing, fixed-term contracts (CDD), and permanent placements (CDI). The group operates through a network of approximately 70 employment agencies and several specialized brands, including DLSI Emploi, TERCIO-RH for the tertiary sector, and EMO DLSI for wood industry trades. It serves a diverse range of industries by providing recruitment solutions for businesses and career support for job seekers across technical, administrative, and industrial roles. The company's key metrics for 2023 included 220 permanent employees and revenue of €204.5 million.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for D.L.S.I. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-20 11:00
Notice of Dividend Amount
Groupe DLSI - Mise en paiement du dividende 2025
French 189.0 KB
2025-05-14 10:55
Pre-Annual General Meeting Information
Groupe DLSI - Avis réunion valant convocation AGO 19-06-2025
French 496.6 KB
2025-05-12 08:50
Pre-Annual General Meeting Information
Groupe DLSI - Avis réunion valant convocation AGO 19-06-2025
French 496.6 KB
2025-05-02 15:20
Capital/Financing Update
Groupe DLSI - Transfert contrat de liquidité auprès de PORTZAMPARC BNP PARIBAS …
French 301.5 KB
2025-04-28 11:30
Audit Report / Information
Groupe DLSI - Rapport sur les comptes consolidés 2024
French 1.1 MB
2025-04-28 11:30
Related Party Transaction
Groupe DLSI - Rapport spécial sur les conventions réglementées 2024
French 440.4 KB
2025-04-26 07:00
Earnings Release
Groupe DLSI - Chiffre d'affaires 1er trimestre 2025
French 285.8 KB
2025-04-25 17:45
Earnings Release
GROUPE DLSI - Chiffre d'affaires 1er trimestre 2025
French 285.8 KB
2025-03-28 07:00
Earnings Release
Groupe DLSI - Résultat 2024
French 292.9 KB
2025-03-27 17:45
Earnings Release
Groupe DLSI - Résultat 2024
French 292.9 KB
2025-02-15 07:00
Earnings Release
Groupe DLSI - Chiffre d'affaires 2024
French 288.3 KB
2025-02-14 17:45
Earnings Release
Groupe DLSI - Chiffre d'Affaires 2024
French 288.3 KB
2025-01-25 07:00
Board/Management Information
Groupe DLSI - Nouvelle composition du Conseil de Surveillance
French 290.1 KB
2025-01-24 15:10
Board/Management Information
Groupe DLSI - Nouvelle composition du Conseil de Surveillance
French 290.1 KB
2025-01-09 13:59
Major Shareholding Notification
Franchissement de seuils
French 214.0 KB

Automate Your Workflow. Get a real-time feed of all D.L.S.I. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for D.L.S.I. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.